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Zusammenfassung 
Die Haut, die Schnittstelle zwischen dem Körper und der Umgebung, ist das größte 
Organ des Körpers und hat zahlreiche Funktionen. Eine davon ist, dass die Haut die 
erste Verteidigungsline des Immunsystems darstellt. Wichtige Vertreter des 
Immunsystems in der Haut, mit denen wir uns in dieser Arbeit befasst haben, sind 
Antigen-präsentierende Zellen (epidermale Langerhans Zellen) und T Zellen. 
Interessanterweise, ist relativ wenig über das Immunsystem der Haut von Kindern 
bekannt. Aus diesem Grund haben wir versucht, ein weiteres Stück des „Kinder 
Immunsystem Puzzles“ zusammen zu setzen. 
Receptor activator of NF-κB (RANK) ist ein Oberflächenrezeptor der auf vielen Zellen 
exprimiert wird. In menschlicher Haut wurde er auf Langerhans Zellen beschrieben 
wo er deren Lebensdauer erhöht. Es gibt jedoch Hinweise, dass andere 
Zellpopulationen innerhalb der Haut ebenfalls RANK exprimieren, allerdings wurde 
noch nicht gezeigt um welche es sich dabei handelt. Bislang wurde berichtet, dass 
etwa 95% aller Langerhans Zellen in adulter menschlicher Haut RANK exprimieren. 
Unsere umfassenden Analysen unter Verwendung mehrerer Methoden haben jedoch 
ergeben, dass die Zahl der RANK+ Langerhans Zellen in menschlicher Haut 
wesentlich geringer ist als zuvor beschrieben. Weiters konnten wir zeigen, dass 
Keratinozyten, nicht aber T Zellen und Melanozyten RANK exprimieren. Die 
Untersuchung unterschiedlicher Altersgruppen ergab einen Anstieg RANK+ 
Langerhans Zellen und einen Abfall RANK-exprimierender-Keratinozyten, mit 
steigendem Alter der Spender, was darauf hindeutet, dass das Immunsystem der 
Haut nach der Geburt noch nicht dem von Erwachsenen entspricht. 
Während man in adulter Haut hauptsächlich  Gedächtnis T Zellen findet, gibt es in 
fötaler Haut fast ausschließlich nur naive T Zellen. Unsere Daten weisen nun 
daraufhin, dass der Wandel von der predominanten naiven T Zell-Population zur 
Gedächtnis T Zell-Population bereits unmittelbar nach der Geburt geschieht.  
Diese Experimente zeigen eindeutig, dass sich das Immunsystem der Haut von 
Kindern und Erwachsenen voneinander unterscheidet und tragen somit zur 
Erweiterung unseres Wissens über das Immunsystem der Haut von Kindern bei. 
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Abstract 
The skin, the interface between the body and the external environment, is the largest 
organ of the body and has multiple functions. One of them is that the skin represents 
the first defence line of the immune system. Important representatives of the skin 
immune system we were working with, were antigen-presenting cells (epidermal 
Langerhans cells) and T cells. Interestingly, little is known about the skin immune 
system of children. For this reason we, tried to compile another, yet unknown piece of 
the “child immune system puzzle”. 
RANK is a surface receptor which is expressed on many different cell types including 
Langerhans cells in adult human skin, where it increases their survival. So far, it is 
reported that about 95% of all Langerhans cells in adult human skin express RANK. 
Other epidermal cell populations also express RANK, but the cell type has not been 
specified yet. Surprisingly, our extensive an analysis using selected methods showed 
that the number of RANK+ Langerhans cells in human skin is much lower than 
described. Additionally we showed that keratinocytes, but neither epidermal T cells 
nor melanocytes express RANK. The analysis of RANK expression in selected age 
groups revealed an increase of RANK+ Langerhans cells and a decrease of RANK+ 
keratinocytes with increasing age of the donors, which indicating that the skin 
immune system after birth differs from the adult one.  
While most T cells in adult human skin show a memory phenotype, the majority of 
fetal T cells are naive. To determine when after birth the switch from naïve to memory 
T cell phenotype occurs, skin samples from selected age groups after birth were 
examined for the presence of  cells using double immunofluorescence staining on 
cryostat sections. Our preliminary data show, that the majority of T cells in newborn 
human skin have already a memory phenotype. The density of memory T cells 
increased with increasing age.  
Our experiments show clearly that the skin immune system from infants and adults is 
different and expands our knowledge about the skin immune system of children.  
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1  Abbreviations 
7-AAD 7-amino-actinomycin D 
APC  Allophycocyanin 
BDCA  Blood dendritic cell antigen 
BSA  Bovine serum albumin 
CCL  CC-chemokine ligand 
CCR  Chemokine receptor 
CD  Cluster of differentiation 
CLA  Cutaneous lymphocyte-associated protein 
CXCL  CXC-chemokine ligand 
DC    Dendritic cell 
E-selectin Endothelial-cell selectin 
EDTA  Ethylenediaminetetraacetic acid 
EGA  Estimated gestational age 
FACS  Fluorescence-activated cell sorter 
FasL  Fas ligand 
FCS  Fetal calf serum 
FITC  Fluorescein-isothiocyanate 
GM-CSF Granulocyte-macrophage colony-stimulating factor 
HLA-DR Human leucocyte antigen-DR 
ICAM  Intercellular adhesion molecule 
IDO  Catabolizing enzyme ideolamine 2,3-dioxygenase 
IFN  Interferon 
Ig  Immunoglobulin 
IL  Interleukin 
LC      Langerhans cell 
K  Keratin 
mAb  Monoclonal antibody 
MACS Magnetic-activated cell sorting 
MADCAM1 mucosal vascular addressin cell-adhesion molecule 1 
MHC   Major histocompatibility complex  
mm    Millimeter 
NF-κB  Nuclear factor-κB 
NK cell Natural killer cell 
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NKT cell Natural killer T-cell 
NLR     Nucleotide-binding domain, Leucine-Rich repeat containing protein 
PBMC Peripheral blood mononuclear cell 
PBS  Phosphate-buffered saline 
PE  Phycoerythrin 
PRR  Pattern recognition receptor 
P-selectin Platelet selectin 
RANK  Receptor activator of NF-κB 
RANKL Receptor activator of NF-κB ligand 
RPMI  Roswell Park Memorial Institute 
TCR  T-cell receptor 
TGF  Transforming growth factor 
TH cell T helper cell 
TLR    Toll-like receptor 
TNF  Tumour necrosis factor 
TRAIL  TNF-related apoptosis-inducing ligand 
Treg cell Regulatory T-cell 
UV      Ultraviolet 
VLA-4  Very late antigen 
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2  Introduction 
2.1  Skin  
The skin is the largest organ of the body and represents an interface between the 
body and the external environment. It is a multifunctional organ, which represents a 
barrier against ultraviolet (UV) light, as well as biological, chemical, and mechanical 
insults. The skin protects the body from dehydration or massive absorption of water, 
functions as a thermo regulator and sense organ, and it also represents the first 
defence line of the immune system.   
Human skin is organised in three layers, including epidermis, dermis and hypodermis 
(Figure 1). The epidermis has an ectodermal origin, while the dermis and the 
hypodermis are of mesenchymal origin1-3. The epidermis and dermis are connected 
by the dermal-epidermal junction, which is synthesised by basal keratinocytes and 
dermal fibroblasts4. 
The skin is not built up equally; variations like thickness (varying from 1 to 4 mm), 
density of melanocytes and distribution of epidermal appendages are just few 
regional differences4. Palms, soles, and foreskin are hairless, whereas the rest of the 
body is covered by hair-bearing skin.  
 
                              
                             Figure 1. A diagram of the skin5 
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2.1.1  Epidermis 
The epidermis is a stratified, non-vascularized epithelium that renews itself 
continuously; its thickness varies between 75 and 600 µm (palms and soles). 
Approximately 90-95% of the epidermal cell types are keratinocytes, which undergo 
the specific differentiation progress of keratinization, resulting in the production of 
corneocytes which shed from the skin surface within time. Other epidermal cell types 
are melanocytes, Merkel cells, T cells and bone marrow-derived Langerhans cells 
(LCs)4;6. 
The epidermis is arranged in four layers (Figure 2): 
a. The stratum basale is the deepest layer of the epidermis and consists of 
keratinocytes, melanocytes, Merkel cells and T cells7. The keratinocytes in this 
layer have stem cell-like properties and divide constantly by mitosis, which leads 
to a movement of the new daughter cells towards the skin surface5. 
b. The stratum spinosum contains several layers of keratinocytes with a limited 
capacity for cell division5. Also sentinels of the immune system, called LCs are 
found beside T cells in the stratum spinosum7. 
c. The stratum granulosum consists of non-dividing keratinocytes which contain 
granules that are filled with keratohyalin. The nuclei and organelles of these cells 
break down, also they flatten due to successive push to the skin surface6. 
d. The stratum corneum is the outermost layer of the epidermis that contains many 
sheets of flattened, scalelike corneocytes. This layer is cornified and acts as the 
actual protection of the skin6. 
 
 
 
Figure 2. A diagram of epidermal layers5 
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2.1.2  Dermis 
The dermis is deeper and much thicker than the epidermis and can be divided into an 
upper papillary dermis and a lower reticular dermis. Its thickness varies, depending 
on the anatomic location (e.g. the back and the palms have a much thicker dermis 
than the eyelids)4. The dermis is made up of an extracellular matrix composed of 
fibrous and non-fibrous proteins, a wide network of blood vessels providing nutrient 
supply for the stratum basale of the epidermis; lymphatic vessels, nerves, muscles, 
sweat glands, sebaceous (oil-secreting) glands, hair follicles, resident and trafficking 
cells4;5. The main cell type of the dermis is the fibroblast. Besides it also harbours 
other cell types such as dermal dendritic cells, plasmacytoid dendritic cells, T cells 
(CD8+ T cells, T helper 1 [TH1] cells, TH2 cells, TH17 cells, regulatory T cells [Treg 
cells], natural killer T cells, γδ+ T cells), macrophages, natural killer cells, and mast 
cells8;9.   
 
2.1.3  Hypodermis 
The hypodermis is a subcutaneous tissue that is in fact not part of the skin. It binds 
the dermis to the underlying bones or muscles, stores lipids, regulates the body 
temperature, and insulates and cushions the body (the hypodermis contains 50% of 
body fat)5. Adipocytes, macrophages and fibroblasts are also present4. 
 
2.2  Cell types of the skin 
2.2.1  Keratinocytes 
Keratinocytes are the prevalent cell type in the epidermis and account for more than 
90% of all cells. Keratinocytes of the stratum basale are anchored by 
hemidesmosomes to the basement membrane that separates the epidermis from the 
dermis10. Adjacent keratinocytes of all layers are generally interconnected by 
desmosomes11, tight junctions, and adherens junctions12. Keratinocytes contain 
melanosomes, to store the skin color pigment melanin, which is synthesised by 
melanocytes13. 
Keratinocytes, produce the protein keratin (K) as part of their cytoskeleton. Keratins 
are one of the most potent epithelial markers and play an important role for the 
mechanical stability and integrity of epithelial cells and tissues. Two types of keratins 
can be distinguished, based on their pH-value. Type 1 keratins are acidic (K9-10, 
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K12-28, and K31-K40), whereas type 2 keratins are neutral/basic (K1-K8 and K71-
K86)14. Keratinocytes express keratin polypeptides in pairs, composed of a type 1 
and a type 2 keratin, but the constitution pattern of keratins depends on the type of 
keratinocytes. K5 and K14 are expressed in basal keratinocytes, suprabasal ones 
express K1 and K10. The keratinocytes in the stratum granulosum express K2 and 
K11, whereas those in the plantar region express K94.  
Humans have 54 keratin genes and at least 26 are specifically expressed in the hair 
follicle14. The keratin genes are clustered at two chromosomal sites. Type 1 keratins 
(except K18) are located on chromosome 17q21.2, and type 2 keratins (including 
K18) are found on chromosome 12q13.1315. 
Keratinocytes are not only bricks of the epidermis, they also function as immune 
sentinels, because of their ability to express toll-like receptors (TLR) and nucleotide-
binding domain, leucine-rich repeat containing proteins (NLRs), which recognise 
pathogen-associated molecular patterns and danger-associated molecular patterns8. 
The activation of extracellular (TLR1, 2, 4, 5 and 6) or intracellular (TLR3 and 9)16 
TLRs in keratinocytes, results in the activation of the nuclear transcription factor-κB 
(NF-κB), leading to the production of antimicrobial and antiviral peptides, chemokines 
and cytokines17. If NLRs get activated by irritants or toxins, pro-interleukin (IL)-1β and 
pro-IL-18 will get cleaved by caspase 1 to generate the active pro-inflammatory 
cytokines IL-1β and IL-1818.  
The constitutive expression of numerous cytokines like IL-1, IL-6, IL-10, IL-18 and 
tumour necrosis factor (TNF)19 by keratinocytes, makes them an important cytokine 
secreting source.  
During inflammation, keratinocytes are also capable to attract different cell types into 
the skin by secreting a wide range of chemokines. Activated keratinocytes are able to 
recruit effector T cells to the skin by expressing CC-chemokine ligand (CCL)20, CXC-
chemokine ligand (CXCL)9, CXCL10 and CXCL1118, whereas neutrophils are 
attracted through CXCL1 and CXCL818. Furthermore, LC precursors are decoyed to 
the epidermis caused by the release of CCL20/MIP3α20. 
 
2.2.2  Melanocytes 
Melanocytes represent 2-5% of all epidermal cells21, descend from neural crest and 
migrate into the basal cell layer of the epidermis4. They have a dendritic morphology 
and express constitutively  S10022, bcl-223;24, c-kit/CD11725 and vimentin26. As 
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melanocytes are the only cell population expressing CD117, this marker can be used 
to identify these cells in the epidermis27. 
Melanocytes synthesize the skin color pigment melanin within melanosomes by a 
biochemical process named melanogenesis28. During this process, melanin is 
produced from the substrate tyrosine by the enzymatic activity of tyrosinase and 
stored in melanosomes4. All humans have about the same quantity of melanocytes 
and various skin colors result from different amounts of produced and stored 
melanin5. 
Melanocytes are also able to constitutively produce IL-1α, IL-1β, IL-3, IL-6, TNFα and 
transforming growth factor (TGF) β21;29. These cytokines contribute to the regulation 
of an inflammation within the skin. 
 
2.2.3  Merkel cells 
Since their discovery in 1875, the role and origin of Merkel cells has been researched 
extensively30. These cells are located in the epithelial sheath of hair follicles and in 
the basal layer of the epidermis4, and represent between 0.2 and 5% of epidermal 
cells31;32. In hair follicles Merkel cells are rarely associated with nerve endings, 
whereas those in the epidermis are in close contact with terminal nerves33 and form 
the Merkel cell-neurite complex. However there is no evidence of a synaptic 
transmission34. Merkel cells contain melanosomes like keratinocytes, and are 
attached to them by desmosomes13.  
The cytokeratins 1835 and 2036;37 give Merkel cells epidermal characteristic features. 
Antibodies against these cytokeratins can be used to identify Merkel cells in the skin. 
Furthermore, neuroendocrine markers including chromogranin A38-40 and the protein 
gene product 9.541;42 are used to detect Merkel cells. 
The origin of Merkel cells is not evidenced yet, but two hypotheses are circulating 
among experts. On the one hand, the neural crest hypothesis exists which proposes, 
that Merkel cells are derived from the neural crest43. On the other hand the epidermal 
origin hypothesis, based on the presence of cytokeratin 20 and desmosomes, 
assumes that Merkel cells have an epidermal origin44-47. Recent findings showed that 
during embryonic development, Merkel cells arise by the differentiation of epidermal 
progenitors48. In adults, Merkel cells are not replaced by proliferation of differentiated 
Merkel cells; a cell type originating from epidermal stem cells, undergoes a slow 
turnover and replaces the old ones48.  
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2.2.4  T cells 
T cells, derive from a common lymphoid progenitor, immigrate to the thymus, where 
they undergo positive and negative selection49. The outcome is a small fraction of 
immature CD4+ and CD8+ thymocytes which show low affinity for self-peptide/major 
histocompatibility complex (MHC)50. These naive T cells express high levels of CCR7 
and CD62L, enabling these cells to home to the T cell zones in secondary lymphoid 
organs51. Notably, in the extra-thymic environment, the positive selection continues 
through dendritic cells (DC) by constant T cell receptor (TCR) interaction with self-
peptide/MHC ligands49 as described later. To keep the post-thymic naive T cells in 
interphase and alive52;53, an interaction with IL-7 and self-peptide/MHC molecules is 
necessary54. Interestingly, a small population of cells, termed fibroblastic reticular 
cells, which is found in secondary lymphoid organs, is secreting CCL21 and CCL19 
(the ligands for CCR7) and IL-751;55. 
If an antigen enters the body, antigen-presenting cells uptake, process and present it 
on MHC I or II to T cells in the secondary lymphoid organs. Signalling by the TCR 
alone is not enough to activate T cells; in addition, co-stimulation via CD28 with 
CD80/CD86, IL-2 release from T cells, as well as the release of antigen presenting 
cell-derived cytokines like IL-12, IL-15 and interferon α (IFNα) are necessary to 
convert naive T cells to effector T cells56-59. Upon activation, some T cells (CD4+) 
might either migrate to the B cell follicles in the lymph node or the spleen, where they 
stimulate   B cells; or CD4+ and CD8+ T cells enter the circulation where they respond 
to an inflammation in the periphery60. 
 
2.2.4.1 T cells possess different homing phenotypes for the skin and the 
gut 
Two subsets of effector T cells can be distinguished, dependent on their preferential 
homing capacity for cutaneous or intestinal tissues61. One subset expresses the 
α4β7-integrin, the ligand of which is the mucosal vascular addressin cell-adhesion 
molecule 1 (MADCAM1)62 and is expressed by endothelial cells of the intestinal tract 
and attendant lymphoid tissues under steady state conditions63. Most of the skin 
resident T cells, representing the second subset, express cutaneous lymphocyte-
associated protein (CLA)64, which is the ligand for E- and P-selectin. To support T 
cell rolling under non-inflamed conditions, dermal microvessels constitutively express 
E- and P-selectin in a sufficient way65. The levels of E- and P-selectin expression 
 21  
  
increase during an inflammation in the tissue, which causes an enhanced T cell 
recruitment to the inflamed region66-70. For a long time, it was thought that the identity 
and localisation of the lymph nodes determine the tissue-homing-receptor profile on T 
cells71;72, but recent data indicate that the site from where DCs acquire an antigen 
constitutes the phenotype73. 
To regulate the trafficking of effector T cells to intestinal or cutaneous sites, 
chemokine receptors play an important role74. In the blood circulating α4β7-integrin+ 
T cells express CCR975-78 and its ligand CCL25 is selectively and constitutively 
expressed by human intestinal epithelial cells75;76;79. Most of the CLA+ T cells in 
peripheral blood express CCR4 and CCR1080-84. CCL17 (the ligand of CCR4) is low 
expressed by skin venules, but its expression increases during an inflammation80, 
whereas CCL27 (the ligand for CCR10) is constitutively expressed by skin 
keratinocytes81-84. 
 
2.2.4.2 Memory T cells 
Upon elimination of the pathogen, most of the antigen-specific effector T cells die 
because of a lack of IL-7 and/or TCR signaling52;54. Additionally, Treg cells are able to 
regulate T cells negatively, by reducing proliferation and facilitated apoptosis49. This 
widespread death of T cells is necessary to restore the steady state in the periphery, 
but a small fraction of these antigen-specific T cells (about 5%) survive to become 
long-lived memory T cells52, which can respond quickly to a secondary pathogen 
challenge85-87. Two types of memory T cells are described: (a) “central” memory cells, 
which return from the periphery to the lymph nodes due to the expression of the 
homing receptors CCR7 and CD62L, and (b) “effector” memory cells, which stay in 
the periphery, and have down regulated CCR7 and CD62L88-90. Effector memory T 
cells are able to enter the blood and migrate at another site of the periphery, to 
sustain a memory effect in the whole periphery of the body88-90. When the pathogen 
is cleared, antigen-specific memory T cells become effector memory T cells, which 
gradually switch to central memory T cells over time91. The mechanism behind this 
process is largely unknown.  
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2.2.4.3 Proliferation capacity of T cells 
The number of naive T cells remains relatively stable, because they do not undergo 
cell division, whereas central memory T cells proliferate every 2-3 weeks53. Central 
memory T cells express high levels of CD127 and CD122 on their surface, which 
allows them to interact with IL-7 and IL-1554. IL-7 is important for their survival as it is 
for naive T cells, while IL-15 is necessary for their intermittent homeostatic 
proliferation54.   
Effector memory T cells show also homeostatic proliferation, which is largely driven 
by IL-1592, but it is very slow compared to central memory T cells92;93 leading to a 
shift towards central memory T cells92;94. According to a recent study, memory T cells 
in the periphery show the ability to resist apoptosis longer than their counterparts in 
secondary lymphoid organs95, which is in contrast to the early mentioned view. 
Although memory T cells in lymphoid and peripheral sites are able to proliferate, the 
number of antigen-specific T cells steadily decreases within time after the pathogen 
is eliminated91;96;97.  
 
2.2.4.4 Activation of memory T cells  
In case of a recurrent infection, memory T cells in the periphery can function as 
sentinels, which alert the immune system by producing chemokines and pro-
inflammatory cytokines, or by limiting the early pathogen replication until the arrival of 
secondary antigen-specific effector T cells from the lymph nodes91. The activation of 
memory T cells in the periphery may be explained by two mechanisms. Cells of the 
innate immune system can indirectly act on memory T cells in the periphery by 
releasing pro-inflammatory cytokines, like type 1 interferons, IL-12 and IL-18, to 
induce memory T cell effector functions98-100. Also it has been proven that DCs in the 
periphery can directly interact with memory T cells and activate them101. Thus, 
memory T cells can be activated in an antigen-dependent and antigen-independent 
way91.  
 
2.2.4.5 T cells in the skin 
In normal human skin, over 90% of T cells are found in the dermis102, whereas only a 
small fraction of T cells reside in the basal and suprabasal keratinocyte layer of the 
epidermis102-106. Approximately 1x106 T cells are found in 1 cm2 normal human adult 
skin107. Most of the T cells in human skin express TCR αβ heterodimers103;108-110, and 
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only a minor population of T cells belong to the TCR γδ lineage103;103;108-112. The 
functional role of skin-resident γδ T cells is not understood, but data in a recent 
publication showed that they are able to secrete insulin-like growth factor 1 upon 
activation and seem to be involved in wound healing113.  
Multiple isoforms of CD45 can be generated by alternative splicing of the extracellular 
domain of the molecule, and can be used to distinguish between naive and memory 
T cells.114. In adult human skin, naive T cells comprise 5-19% of all CD3+ cells and 
express CD45RA106. Memory T cells constitute about 90% of the T cells in the skin 
and are all CD45RO+, whereas only about 80% of all CD3+ cells are CLA+, 90% of 
the memory T cells express CLA106. While the distribution of naive (CD3+CD45RA+) 
and memory T cells (CD3+CD45RO+) in adult blood is quite similar to the skin115, only 
10-25% of the CD3+ blood cells are positive for CLA116. Most recent data provide 
evidence that under resting conditions, 98% of all CLA+CD3+ cells are found in the 
skin107. 
While many reports exist about T cells in adult human skin, less is known about their 
appearance in the developing skin (prenatal – adult). Recent findings indicate, that 
within human fetal skin CD3+CD45RA+, CD3+CLA+ and CD3+CD45RO+ cells are 
already found in low numbers in the 18th week of estimated gestational age (EGA)117. 
The numbers of CD3+CLA+ and CD3+CD45RO+ cells do not appreciably rise until the 
30th week of EGA, whereas, the density of CD3+CD45RA+ cells multiplies, leading to 
a distribution which shows three times more naive than memory T cells within the 
skin of a fetus117. A similar distribution of naive and memory T cells was described for 
the cord blood of newborn children115. 
 
2.2.5  Dendritic cells 
DCs are important initiators of the innate and adaptive immune response. They are 
the most potent antigen-presenting cells and are found in peripheral tissues. In the 
skin, DCs can be divided according to their anatomical localisation. In the epidermis 
one can detect LCs, and in the dermis interstitial DCs and plasmacytoid DCs are 
found8. DCs reside in an immature state in the periphery and are able to identify 
foreign antigens by random sampling their environment by phagocytosis118-120, 
macropinocytosis121 and receptor-mediated endocytosis122;123. The lack of T cell 
activating receptors, and the low expression of MHC I and MHC II in the immature 
state, makes them unable to activate T cells124. The recognition of a foreign peptide 
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results in the activation of the NF-κB pathway and finally in the maturation of the DC, 
which is accompanied by the expression of co-stimulatory molecules and the 
enhanced expression of antigen-presenting MHC molecules125. This is followed by 
migration into the T cell areas of lymphoid tissues such as the lymph nodes or 
spleen, which is guided by a chemotactic cytokine gradient. During this migration 
process, DCs mature and loose their ability to capture antigens. Antigens are 
processed, and displayed on either MHC I or MHC II molecules, to be presented to 
naive T cells126. The interaction with receptors on T cells, is accomplished by 
molecules such as CD40, CD54, CD58, CD80 and CD86127;128. On which MHC 
molecule the foreign antigen is displayed, depends on the kind of antigen. CD8+       
T cells interact with MHC I, whereas CD4+ T cells are activated through MHC II124. To 
avoid an excessive immune response, activated T cells induce apoptosis in DCs by 
expressing Fas Ligand, TNF-α and TNF-related apoptosis-inducing ligand (TRAIL)129. 
DCs also have the unique ability among antigen-presenting cells, to cross-present 
antigens to naive T cells125;130. Additionally, in case of an adaptive mediated immune 
response, DCs are able to direct it towards a type-1 and/or type-2 reaction131. 
Beyond these skills, DCs are involved in the induction of tolerance in the thymus 
(central tolerance) and in lymphoid organs (peripheral tolerance). A small number of 
DCs move from the periphery to the lymph nodes, even in the absence of invading 
pathogens in the steady state125. These tolerogenic DCs do not activate T cells or 
lead to a clonal expansion, because of the release of IL-10 and catabolizing enzyme 
ideolamine 2,3-dioxygenase (IDO) which enable T cell anergy, T cell death and      
Treg cell proliferation132. The role of LCs in mediating immune tolerance is not fully 
delineated, whereas evidence for the tolerogenic function of dermal DCs exist133. 
 
2.2.5.1 Langerhans cells 
Paul Langerhans, a medical student in Berlin, first identified dendritic cells in the 
epidermis in 1868, which he supposed to be nerve cells of the skin134;135. One 
century later it was appreciated, that he discovered a new population of leukocytes, 
which was named after him130. LCs represent the first line of immunological defence 
to the external environment. They are strategically positioned in the epidermis and 
form a network with their external dendrites4. LCs account for 3-5% of epidermal cells 
in humans136 and derive from the bone marrow137. Since the discovery of Birbeck 
granules in 1961138, it has been possible to distinguish between LCs and other cells, 
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because this cytoplasmic organelle is found only in LCs. This was the only method to 
identify LCs for many years, until it was shown that Langerin (CD207), a mannose-
specific C-type lectin receptor, which is localised to Birbeck granules139 and highly 
expressed by human and mouse LCs140, can be used as a marker to identify LCs 
within the epidermis, too. Until recently, it was thought that Langerin is only 
expressed by LCs, but newest studies showed that a murine population of dermal 
DCs is also able to express this receptor141-144, whereas a human counterpart is not 
found yet. 
LCs are present in an immature state and in the human epidermis express CD1a, 
CD39, CD45, CD207, Birbeck granules, chemokine receptor (CCR) 6, CLA,             
E-cadherin, MHC I and MHC II143;145;146. Upon activation, LCs mature and upregulate 
the expression of CD40, CD45, CD80, CD83, CD86, CCR7, very late antigen (VLA) -
4, intercellular adhesion molecule (ICAM) -1, MHC I and MHC II124;125;147-154. 
While it is a matter of fact that LCs are derived from bone marrow-derived 
progenitors155, it is unsolved whether and if so, how LCs migrate into the epidermis 
under non-inflamatory conditions. Three different viewpoints exist: first, in mouse 
experiments it was shown that LCs can divide in the epidermis156. Second, it was 
described that dividing LC-precursors (CD207+CD14+) reside in the dermis and that 
the final migrating step is perhaps controlled by the release of TGFβ and 
CXCL14157;158 from keratinocytes. Third, it was demonstrated that LCs derive from 
CLA-expressing LCs precursors159, which were generated in the bone marrow, 
released to the blood, through which they reach the skin and populate the epidermis.  
Only during an inflammation process in the skin, a recruitment of LC-precursors from 
the blood is described156. To enter the epidermis, LC-precursors depend on the 
release of the keratinocyte-derived cytokine TGFβ160 and the chemokine CCL20161. 
This cytokine is necessary for the formation of Birbeck granules162, whereas CCL20 
attracts LC-precursors20;163. 
 
2.2.5.2 Dermal dendritic cells  
Three different subsets of antigen-presenting cells are found in the human dermis. 
HLA-DRhiCD14-CD1a+CD207- DCs; HLA-DRhiCD14+CD1a- DCs and HLA-
DRloCD14+CD1a-FXIIIa+CD163+ dermal macrophages164-169. CD14-CD1a+ DCs are 
able to induce a less efficient proliferation of allogeneic T cells compared to LCs167;170 
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and are distinct from LCs166;169. CD14+ cells include both migratory DCs and 
nonmigratory macrophages.   
It is known that LCs can cross-present antigens to CD8+ T cells and are potent  
inducer of a TH1 cell response, but it seems that the role of  dermal DCs is another 
one. They facilitate B cell immunoglobulin class switching and initiating follicular              
TH cells170;171.   
Plasmacytoid DCs are also localised in the dermis, but they are rarely found in 
healthy skin167;172. They express CD123, blood dendritic cell antigen (BDCA) -4 and, 
the only exclusive marker for plasmacytoid DCs, BDCA-2173. A special feature of 
plasmacytoid DCs is that they express a wide range of TLRs which makes them very 
competent to recognise microbial pathogens174. Furthermore, they are the most 
potent producers of Type I IFNs (IFN-α, β, ω) in case of a viral infection175;176.  
 
3  The role of RANK and RANKL in the immune 
system 
RANK and its ligand (RANKL) are both members of the TNF receptor superfamily129. 
RANK is constitutively expressed on DCs and osteoclasts whereas RANKL is not 
found on resting T cells, osteoblasts or keratinocytes, but is expressed upon 
activation of these cells129. The RANK-RANKL-system is associated with numerous 
physiological processes including bone remodelling, lymph node formation, 
interactions between DCs and T cells, DC survival, the regulation of DC functions 
and the formation of lactating mammary glands in pregnancy177-184. RANK can be 
detected on some cancer cells, including prostate and breast cancers and may play a 
role in the induction of tumor cell proliferation185;186. RANK and RANKL are also 
expressed in astrocytes of the brain and seem to be important for the control of 
female body temperature and the central fever response in inflammation187.  
In the periphery, interactions between RANK on DCs and RANKL on activated T 
cells, lead to a prolonged survival of DCs188;189, an increased production and release 
of proinflammatory cytokines like IL-15, IL-12, IL-6 and IL-1190;191 through DCs, and it 
seems that several DC functions, such as the activation of T cells are enhanced192. 
The RANK-RANKL-system is very well studied on osteoclasts and osteoblasts in 
bones, but less is known about this system in other tissues. UV irradiation in the skin 
leads to an upregulation of RANKL on keratinocytes which interact with LCs through 
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the RANK-RANKL-system and activate them178. These activated LCs respond by 
upregulation of certain cytokines such as IL-6, IL-10 and TNF-α and molecules such 
as CD86 and CD205 inducing preferentially the expansion of CD4+CD25+ Treg cells 
thus, suppressing an immune response in the skin129. This interplay of keratinocytes 
with LCs and LCs with Treg cells might be one reason for the immunosuppressive 
effect of UV irradiation129. It is also reported that approximately 95% of skin resident 
LCs are RANK+ and that RANKL knockout mice show LC numbers in the skin that 
are reduced to 50% as a consequence of an inferior DC survival180.  
CD40 and CD40L are members of the TNF family129. RANKL and CD40L are both 
expressed on activated T cells and show functional similarities such as the enhanced 
survival and activation of DCs188;192. The interaction of CD40 and CD40L leads to an 
altered expression of MHC II, CD54, CD80 and CD86 on DCs. Such an effect is not 
described for the interaction of RANK and RANKL129. Furthermore, CD40L is only 
expressed on activated CD4+ T cells, whereas RANKL is found on activated CD4+ 
and CD8+ T cells190;192. In kinetic experiments CD40L showed highest expression 
levels between 6 and 8 hours; a downregulation to resting levels was observed 
between 24 and 48 hours which indicates that the CD40-CD40L-system controls the 
initial priming stage188;190. In contrast, highest RANKL levels were measured after 48 
hours, leading to the conclusion that the RANK-RANKL-system is active at later time 
points188;190. Differences have also been described in the control of an immune 
response. While DCs can interact with T and B cells via the CD40-CD40L-system, it 
is only possible for them, to interact with T cells by the RANK-RANKL-system, since 
B cells do not express RANK129. 
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4  Aim of the study 
Every year dozens of new publications about the skin immune system are published, 
but most of these studies were performed with mice or adult human skin. Knowledge 
about the phenotype of immune cells, such as epidermal LCs and T cells in the 
developing human skin after birth is scarce.  
In our lab we were able to show that the morphology and the distribution of LCs is 
similar in human skin from infants and adults. However, the numbers of LCs in infant 
epidermis are reduced compared to adults193.  As RANK is an important molecule for 
LC survival, we tested whether LCs and other skin cells already express RANK 
around birth. 
As the predominant T cells in human fetal skin are naive T cells, while those in adult 
skin are memory T cells we wanted to explore, when the switch from naive to 
memory T cells occurs in the skin. 
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5  Results and discussion 
5.1 Analysis of RANK expression in the developing 
human epidermis after birth 
Barbaroux et al. have recently published that 95% of all CD1a+ cells in adult human 
epidermis express RANK180. In their study they have isolated epidermal cells from 
normal human skin biopsies, enriched LCs via ficoll flotation and analyzed them by 
flow cytometry for CD1a and RANK expression180. They described two RANK+ cell 
populations, LCs and an as yet undefined epidermal population180. They speculated 
that the latter cells may be keratinocytes, but did not further investigate this180. We 
wanted to address this question and analyzed single cell suspensions prepared from 
normal human breast and foreskin. Unlike Barbaroux et al., we have not enriched for 
LCs because our intention was to characterize all RANK+ epidermal cells. To exclude 
the possibility that our samples may be inflamed, mRNA levels of random samples 
were tested for E-selectin67 and ICAM-1131 expression by quantitative real-time PCR 
(performed by Nousheen Iram, Elbe-Bürger group; Laboratory of Cellular and 
Molecular Immunobiology of the skin, Department of Dermatology, Medical University 
of Vienna). Only donors with negative to low gene expression compared with the 
positive control were selected for further analysis (data not shown). 
Epidermal cells were stained with anti-CD1a and anti-pancytokeratin monoclonal 
antibodies (mAbs) to distinguish LCs and keratinocytes, respectively. T cells and 
melanocytes were labeled with anti-CD3 and anti-CD117 mAbs, respectively. We 
found that LCs and keratinocytes express RANK, while T cells and melanocytes are 
definitely not RANK+ (Figure 3A). To confirm that LCs and keratinocytes are the only 
two cell populations within the epidermis which are RANK+, triple staining with RANK, 
CD1a and pancytokeratin was performed. Indeed, we found that epidermal cells 
gated for RANK expression mainly contained LCs and keratinocytes (Figure 3B). 
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Figure 3. LCs and keratinocytes but not T cells and melanocytes express RANK. (A) Epidermal 
single cell suspensions were prepared from normal human foreskin [31 years (Exp. 1), 1 year (Exp. 2) 
and 11 years (Exp. 3)], and double stained with the indicated markers. Dead cells were excluded by 7-
amino-actinomycin D (7-AAD) uptake. Dot plots show 100,000 cells and are representative of 3-21 
experiments. (B) To analyze all RANK+ epidermal cells, a triple staining was performed (36 year-old 
foreskin). Viable cells were gated for RANK expression. 
 
Using flow cytometry, freshly prepared epidermal single cell suspensions from human 
donors of selected age groups were labeled with anti-RANK and anti-CD1a mAbs to 
analyze the frequency of RANK+ LCs within human epidermis. When analyzing the 
percentage of RANK+CD1a+ cells, we identified a significant increase of these cells 
with age. In foreskin from infants (11.16%±8.67) and old children (12.87%±9.29) we 
found a significant lower percentage of RANK+ LCs when compared with adult 
foreskin (32.99%±11.5) (Figure 4A, red gates, B). Also adolescent foreskin 
contained fewer RANK+ LCs when compared with adult foreskin, however, this was 
not significant. Additionally, normal human breast skin was analyzed for the presence 
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of RANK+CD1a+ cells in the epidermis to include the percentage of RANK+ LCs from 
another part of the body. Surprisingly, only 12.49% of all LCs were RANK+ (Figure 
4B), which is in contrast to the results of Barbaroux et al180.  
Furthermore, the frequency of RANK+CD1a- cells was determined (Figure 4A, 
yellow gates). Foreskin from infants (96.28%±4.68), old children (93.98%±4.68) and 
adolescents (86.87%±7.07), and normal human breast skin (91.59%±5.3)  showed a 
higher percentage of RANK+CD1a- cells in the epidermis compared to adult 
(64.62%±23.95) foreskin (Figure 4C), but only data obtained from infants and old 
children were significant when compared with adult foreskin.  
 
 
Figure 4. Analysis of RANK+CD1a+ and RANK+CD1a- cells in developing human epidermis. (A) 
Single cell suspensions from foreskin of selected age groups [infant (1 year), old child (10 years), adult 
(31 years)] were labeled with anti-RANK and anti-CD1a mAbs. Dot plots show RANK+CD1a+ (red 
gates) and RANK+CD1a- (yellow gates) cell populations. Dead cells were excluded by 7-AAD uptake. 
Dot plots show 100,000 cells. (B) The diagram displays the percentage of RANK+CD1a+ epidermal 
cells of the indicated age groups. Significant differences between infant and adult (* P<0.05) and old 
child and adult (* P<0.05) RANK+CD1a+ LCs were observed. (C) The diagram shows the percentage 
of RANK+CD1a- epidermal cells of different age groups. A significant difference between infant and 
adult (* P<0.05) and old child and adult (* P<0.05) RANK+CD1a- cells was observed. f.s. = foreskin. 
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5.2 Not all LCs in adult human epidermis express 
RANK 
To test the validity of our flow cytometry data in adult skin, epidermal sheets were 
prepared and labeled with anti-RANK and anti-CD1a mAbs (Figure 5A, B). We found 
that many LCs do not express RANK, what is again in contrast to observations from 
Barbaroux et al.180. The discrepancy of these results cannot be explained at the 
moment. 
Figure 5. Not all CD1a+ LCs in adult human epidermis express RANK. Epidermal sheets from (A) 
belly skin (41 years) and (B) gluteal skin (55 years) were stained with an anti-RANK mAb, visualized 
with an AlexaFluor-546 goat anti-mouse IgG and counterstained with an anti-CD1a-FITC mAb. Arrows 
indicate RANK-CD1a+ cells. Arrowheads indicate RANK+CD1a+ cells. Scale bars: 20 µm.   
 
5.3   Only a minor percentage of in vitro generated LCs 
express RANK 
We next determined the percentage of LCs expressing RANK, when these were 
differentiated in vitro from CD34+ cells isolated from cord blood. Upon culture of 
CD34+ cells with GM-CSF, Flt3L, SCF, TNF-α and TGF-β1194 for 9 days, cells were 
labeled with anti-RANK and anti-CD1a mAbs or with anti-Langerin and anti-CD1a 
mAbs for flow cytometric analysis. Langerin/CD1a staining was performed to confirm 
that the generated cells are indeed LCs. Unfortunately, it was not possible to 
accomplish a Langerin/CD1a/RANK staining. Therefore, it was necessary to correlate 
the percentage of CD1a+ cells in both stainings. The generation, staining and 
recording of the results were performed by Thomas Bauer (Stroble group; Institute of 
Immunology, Medical University of Vienna).  
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The mean of RANK+CD1a+ cells is about 12.12%±7.45 (Figure 6), which 
corresponds with the results obtained for RANK+CD1a+ cells in infant or old child skin 
in the in vivo experiments.  
 
 
Figure 6. In vitro generated LCs. (A) LCs were in vitro generated from CD34+ cells and labeled with 
the indicated mAbs. Only a small fraction of CD1a+ cells express RANK. (B) The diagram displays the 
percentage of in vitro generated RANK+CD1a+ cells.    
 
Thus, similar to our observation with freshly isolated epidermal cells, only a minor 
population of CD1a+ cells express RANK. Double labeling experiments need to be 
performed to test how many Langerin+ cells express RANK. All together our results 
are in direct contrast to those of Barbaroux et al.180 The use of a different isolation 
procedure is one explanation. However, it does not explain the results in epidermal 
sheets.  
The validity of our flow cytometry data is supported by our observations in epidermal 
sheets and in vitro differentiation data of LCs from their precursors  . Experiments are 
planned to investigate whether RANK+ and RANK- LCs represent different LC 
subtypes and also have a different functional capacity. It will be also interesting to 
investigate which factors in the developing skin are responsible for the upregulation 
of RANK on LCs during development. Furthermore, we plan to test when during 
prenatal development RANK expression can first be detected on LCs.  
 
5.4  Keratinocytes express RANK 
Upon identification of RANK+Cytokeratin+ keratinocytes (Figure 3), freshly prepared 
epidermal single cell suspensions from selected age groups were labeled with an 
anti-RANK and an anti-pancytokeratin mAb to determine the frequency of RANK+ 
keratinocytes (Figure 7A). A decrease of RANK+ keratinocytes from infants 
compared to adults was found. The percentage of keratinocytes expressing RANK in 
infant epidermis (0.78%±0.51) is higher compared with those of old children 
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(0.34%±0.14) or adults (0.17%±0.14). In normal human breast skin, the ratio of 
RANK+ keratinocytes is about 0.5%±0.39. 
 
Figure 7. RANK expression on keratinocytes. (A) Epidermal single cell suspensions from infant (1.5 
years) and adult (20 years) foreskin were labeled with anti-RANK and anti-pancytokeratin mAbs. 
Green gates show the percentage of RANK+ keratinocytes. Dead cells were excluded by 7-AAD 
uptake. Dot plots display 100,000 cells. (B) The diagram displays the percentage of 
RANK+Cytokeratin+ cells. f.s. = foreskin; ns = not significant. 
 
The percentage of RANK+ keratinocytes in all age groups is less then 1%. However, 
it is important to put these results in context to the total cell numbers which are 
present in the epidermis. Keratinocytes represent approximately 90% and LCs only 
3-5% of all epidermal cells. If we consider a population of 1000 epidermal cells, then 
only approximately 40 LCs and 900 keratinocytes would be identified. In infants, 
11.16% of all LCs and 0.78% of all keratinocytes are RANK+. Only 4.46 LCs and 7 
keratinocytes would express RANK in our theoretical epidermis, leading to a ratio of 
1:1.51. The total number of RANK+ keratinocytes in infant skin is higher than those of 
RANK+ LCs. In the epidermis of old children we have a ratio of 1:0.59 and in adult 
foreskin 1:0.12, showing that there seems to be a shift from higher RANK+ 
keratinocyte numbers to more RANK+CD1a+ cells. In normal breast skin the ratio is 
1:0.9, which leads to the conclusion that in normal human breast skin, the distribution 
of total RANK+ LCs and keratinocytes is almost equal. 
Our observation that some keratinocytes are able to express RANK, leads to many 
questions. It remains to be determined which keratinocytes express RANK. If 
expressed only on some basal keratinocytes, we plan to analyze whether its 
expression may correlate with proliferating (=Ki67+) keratinocytes. Are RANK+ 
keratinocytes able to interact with RANKL-expressing T cells. If yes, why? It is 
currently unclear why the percentage of RANK+ keratinocytes in infants even though 
not significant, is much higher than in any other age group and what leads to the 
reduction of RANK+ keratinocytes with time? 
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5.5 Staining of naive and memory T cells in human 
dermal single cell suspensions   
To investigate the expression of specific markers on skin T cells, it was necessary to 
first evaluate whether they are sensitive to enzymes used to prepare skin single cell 
suspensions. Therefore, dermal single cell suspensions were prepared and double 
staining were performed with the T cell specific marker CD3 and markers for naive 
(CD45RA) and memory T cells (CD45RO). Unfortunately, neither CD45RA nor 
CD45RO expression was observed (Figure 8), implying that both receptors are 
sensitive to either dispase or liberase or even both enzymes used to separate the 
epidermis from the dermis.  
 
 
Figure 8. Staining of naive and memory T cells in a dermal single cell suspension. A dermal 
single cell suspension was prepared from human adult foreskin (31 years) and labeled with anti-CD3 
and anti-CD45RA or anti-CD45RO mAbs to distinguish naive and memory T cells. Dead cells were 
excluded by 7-AAD uptake. Dot plots display 100,000 cells and are representative of 3 experiments. 
 
5.6 Staining of naive and memory T cells in human 
peripheral blood 
Peripheral blood mononuclear cells (PBMCs) were isolated from buffy coats from 
peripheral blood of healthy adult volunteers. One half of the cells was stained with 
anti-CD45RA, anti-CD45RO and anti-CLA mAbs and analyzed by flow cytometry 
(Figure 9A). The other half of the cells was incubated in dispase II (1 hour, 37°C), 
washed and digested in liberase (2 hours, 37°C) to imit ate the preparation of a 
dermal single cell suspension and to test the dispase and liberase sensitivity of the 
mentioned markers. Afterwards the cells were analyzed by flow cytometry. 
Surprisingly, no significant difference was observed, upon dispase and liberase 
treatment leading to the conclusion that the three tested markers are not sensitive for 
the treatment with dispase and/or liberase (Figure 9B). 
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Figure 9. Staining of naive and memory T cells in PBMCs. (A) PMBCs were isolated from the 
blood of healthy adult donors and stained directly after isolation or (B) incubated with dispase and 
afterwards with liberase and stained with the indicated markers. Dead cells were excluded by 7-AAD 
uptake. Dot plots display 10,000 cells and are representative of 3 experiments. 
 
5.7  Staining of naive and memory T cells in skin 
single cell suspensions   
As we found no difference in the expression levels of naive and memory T cell 
markers in T cells upon liberase treatment compared with the non-treated group, 
single cell suspensions from whole skin were prepared using liberase for digestion of 
the dermis and were stained with anti-CD45RA and anti-CD45RO mAbs. As a 
second marker for memory T cells we have used an anti-CLA mAb. Approximately 
50% of the T cells either expressed CD45RA or CLA, implying that these markers are 
partially sensitive to liberase. CD45RA and CLA showed unequivocal populations 
and no reactivity with an anti-CD45RO mAb was observed (Figure 10). 
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Figure 10. CD45RO molecules are liberase sensitive. Skin single cell suspensions were prepared 
from human foreskin [16 years (Exp. 1), 3 years (Exp. 2)] and labeled with anti-CD3, anti-CD45RA, 
anti-CD45RO or anti-CLA mAbs to distinguish between naive and memory T cells. Dead cells were 
excluded by 7-AAD uptake. Dot plots display 100,000 cells and are representative of 3-11 
experiments.   
 
5.8  Determination of the percentage of naive and 
memory T cells in developing human skin 
Human breast and foreskin samples from selected age groups were triple stained for 
CD3, CD45RA and CLA to determine the percentage of naive and memory T cells. 
Analyzed cells were gated for CD3, and CD45RA is displayed against CLA (Figure 
11A). Sensitivity of CD45RA and CLA molecules for diverse enzymes has already 
been demonstrated, but no report about liberase sensitivity was familiar for us. 
Unfortunately, most of the cells displayed only CD3, implying a loss of CD45RA or 
CLA, which makes it impossible to differentiate between naive or memory T cells in 
skin single cell suspensions. Only a small fraction of naive and memory T cells kept 
their markers, and a third fraction with a similar percentage showed a triple positive 
phenotype. This CD3+CD45RA+CLA+ population has a receptor expression profile 
previously described for regulatory T cells195-198. The obtained data were evaluated 
and displayed in a diagram to show the relation of naive and memory T cells even 
though we are aware that they do not represent the “true” picture for reasons 
described above (Figure 11B). 
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Figure 11. Distribution of naive and memory T cells in skin from selected age groups. (A) A 
single cell suspension was prepared from human foreskin (3.5 years). Left dot plot shows a gate for 
CD3+ T cells. Right dot plot displays the expression of CD45RA and CLA on CD3+ cells. Dead cells 
were excluded by 7-AAD uptake. Dot plots display 100,000 cells and are representative of 3-11 
experiments. (B) The diagram shows the relation of naive (CD3+CD45RA+, white bars) and memory 
(CD3+CLA+, black bars) T cells in human skin. Infant (10 months and 1 year), child (3.5 years, 8 years 
and 8.5 years), adolescent (15 years and 16 years), adult (36 years) foreskin and breast skin (18 
years, 45 years and 49 years) were analyzed. 
 
5.9  Naive T cells are present in infant and adult but 
not in newborn epidermis 
Due to the sensitivity of certain T cell markers to skin cell separation enzymes, 
scientists have developed new methods to isolate T cells from the skin. T cell 
chemoattracting factors and skin explants were used to allow migration of T cells out 
of the skin199. It is a procedure, which takes some days and might lead to a 
modification of the T cell phenotype. Therefore, we decided to use 
immunofluorescence staining of T cells in cryostat sections. Skin sections were 
labeled with anti-CD3, -CD45RA and -CD45RO mAbs. Inflamed samples were 
excluded, based on T cell cluster formations in the epidermis (Figure 12A) and on 
high T cell numbers in the dermis (Figure 12B).  
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Figure 12. Identification of inflamed skin. (A) Cryosections from human foreskin (10 months) were 
labeled with anti-CD3-FITC and anti-CD45RA-PE mAbs. The epidermis shows a cluster formation of T 
cells (arrow), indicating an inflammation. (B) Human foreskin (2 months) was stained with an anti-
CD45RO mAb, visualized with an AlexaFluor-546 goat anti-mouse IgG and counterstained with an 
anti-CD3-FITC mAb. High T cell numbers were detected within the dermis, indicating an inflammation. 
Scale bars: 20 µm. E = Epidermis, D = Dermis. 
 
Upon exclusion of inflamed samples, naive and memory T cell staining was 
performed with newborn, infant, and adult foreskin samples. From each donor and 
staining, at least 10 pictures were taken and analyzed. Unfortunately, it was 
impossible to analyze the dermis from adult foreskin samples due to high levels of 
collagen. Therefore, we have included normal human male breast skin which showed 
lower levels of collagen (Figures 13-15).  
 40  
  
Figure 13. Naive T cells are present in infant and adult, but not in newborn epidermis.  
Cryosections from newborn (3 days), infant (5 months) and adult (31 years) foreskin were labeled with 
anti-CD3-FITC and anti-CD45RA-PE mAbs. No naive T cells were found in the newborn epidermis, 
whereas infant and adult epidermis harbors CD45RA+CD3+ cells. Arrows indicate CD45RA+CD3+ cells 
in the epidermis. Scale bars: 5 µm. E = Epidermis, D = Dermis.   
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Figure 14. Naive T cells are present in newborn, infant and adult dermis. Cryosections from 
newborn (5 days), infant (5 months) and adult (31 years) foreskin were labeled with anti-CD3-FITC 
and anti-CD45RA-PE mAbs. The dermis from adult foreskin was difficult to analyze due to high 
collagen expression. Therefore, normal human adult male breast skin (19 years) was included. 
CD45RA+CD3+ cells (white arrows) were found in the dermis of the indicated age groups. Scale bars: 
20 µm. E = Epidermis, D = Dermis. 
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Figure 15. Memory T cells are present in newborn, infant and adult epidermis and dermis. 
Frozen human foreskin samples from newborn (3 days), infant (6 months) and adult (31 years) 
individuals were labeled with an anti-CD45RO mAb, visualized with an AlexaFluor-546 goat anti-
mouse IgG and counterstained with an anti-CD3-FITC mAb. We used a normal human adult male 
breast skin (19 years) as a control. CD45RO+CD3+ cells were extremely rare in newborn epidermis, 
but their numbers increased with age. CD45RO+CD3+ cells are indicated with arrows (dermis) and 
arrowheads (epidermis). Scale bars: 20 µm. E = Epidermis, D = Dermis. 
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As naive and memory T cells were found in the epidermis and dermis of almost all 
age groups, we decided to enumerate these populations (Figure 16). 
 
 
Figure 16. Frequency of naive and memory T cells in newborn and infant skin. Frozen human 
foreskin samples from newborn (3 to 5 days) and infant (5 months, 6 months and 14 months) 
individuals were analyzed. Diagrams show the relation of naive (CD45RA+CD3+, white bars) and 
memory (CLA+CD3+, black bars) T cells in human skin. T cells numbers in the (A) epidermis and (B) 
dermis were evaluated, by counting naive and memory T cells in different donors on cryosections. At 
least three different, non-inflamed donors from each age group were analyzed. In the epidermis from 
newborns, no CD45RA+CD3+ cells were found, whereas 12.26%±7.67 of all T cells found in the 
epidermis of infants were naive T cells. Most of the epidermal CD3+ cells are memory T cells (100% in 
newborns, 95.3%±8.14 in infants). The distribution of naive and memory T cells is similar in newborn 
(5.77%±4.2 naive T cells, 97.67%±2,72 memory T cells) and infant (5.95%±1.69 naive T cells, 
90.22%±4.89 memory T cells) dermis.  
 
Immunofluorescence staining showed that epidermal T cells are very rare, but 
already present in newborn skin. No naive T cells were found in the newborn 
epidermis. Infants show a small population of CD45RA+CD3+ cells with an average of 
12.26%±7.67 of all T cells found in the epidermis. All epidermal T cells in newborns 
show a memory T cell expression profile, whereas 95.3%±8.14 of infant epidermal T 
cells are CD45RO+CD3+.  
Naive T cells are also present in the newborn dermis. Our results show that 
5.77%±4.2 from newborn and 5.95%±1.69 from infant dermal T cells are 
CD45RA+CD3+ and that 97.67%±2.72 from newborn and 90.22%±4.89 from infant 
dermal T cells have a CD45RO+CD3+ expression profile. These values are already 
comparable to those found in the literature when adult skin was analyzed106. 
We show for the first time that already the newborn skin contains more memory then 
naive T cells. We are aware that more skin samples need to be analyzed to come to 
a definitive conclusion. 
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6  Materials and methods 
6.1  Apparatuses and instruments 
Binocular (Leitz-Austria, Vienna, Austria) 
Buffy Coats (Rotes Kreuz, Vienna, Austria) 
Capillary gab microscope slides, 100 µm (Dako, Glostrup, Denmark) 
Carbon steel surgical blades (Heintel, Vienna, Austria) 
Centrifuge (Heraeus, Vienna, Austria) 
Centrifuge, megafuge 2.0 (Kendro Laboratory Products, Vienna, Austria) 
CO2 incubator (Heraeus, Vienna, Austria)  
Confocal laser scanning microscope, CLSM 510 (Zeiss, Jena, Germany) 
Cryostat (Leica, Wetzlar, Germany) 
FloJo software (Tree Star Inc., Ashland, OR, USA) 
Fluorescence-activated cell sorter (FACSCalibur, BD, Franklyn Lakes, NJ, USa) 
Freezers (-20°C, -80°C) 
Fridges 
Forceps 
GraphPad  Prism 5 Software (GraphPad, San Diego, CA, USA) 
ImmEdge, H-4000 (Vector Laboratories Inc., Burlingame, CA, USA) 
Laminar flow (Holten, Allerod, Denmark) 
LSM image browser software (Zeiss, Jena, Germany) 
Lucia general software  
Neubauer counting champer  
Optical microscope, Nikon eclipse 80i (Nikon Corporation, Tokyo, Japan) 
Pipetman, 1-50 ml (Hirschmann, Eberstadt, Germany) 
Pipette (Gilson, Middelton, WI, USA) 
Scalpel 
Vacutainer CPT 8ml (BD, Franklin Lakes, NJ, USA) 
Vortex Genie 2 (Lactan, Graz, Austria) 
Water bath 
 
6.2  Plastic material 
Cell strainer 70 µm (Falcon, Lincoln Park, New Jersey, USA) 
Gloves 
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Microscope glass cover slips, 24x60 mm (Menzel-Gläser, Braunschweig, Germany) 
Microscope slides, 76x26 mm (Menzel-Gläser, Braunschweig, Germany) 
Microtubes for flow cytometry (Micronic, Lelystad, The Netherlands) 
Petri dishes for tissue culture, 100x20 mm (Costar, Lowel, MA, USA)  
Pipettes, 5, 10 ml (Costar, Lowel, MA, USA) 
Polypropylene tubes, 14 and 50 ml (Falcon, Ulm, Germany) 
Sterile tips, 0.5-10, 1-100 and 200-1000 µl (Costar, Lowel, MA, USA) 
Tissue culture plate, 96-well, flat bottom without lid (BD, Franklin Lakes, NJ, USA) 
Tissue-tek cryomold standard (Salcuna Finetek, Zoeterwoude, The Netherlands) 
 
6.3  Reagents 
7-amino-actinomycin D (Sigma-Aldrich, St. Louis, MO, USA) 
Acetone (Merck, Darmstadt, Germany) 
Ammoniumchloride 
Ammoniumthiocyonate (Merck, Darmstadt, Germany) 
Antibodies: summarized in Table 1 
Betaisodona (Mundipharma, Vienna, Austria) 
Bovine serum albumin, BSA (Sigma-Aldrich, St. Louis, MO, USA) 
Dispase II (Roche Applied Science, Basel, Switzerland) 
DNAse (Invitrogen, Lofer, Austria) 
Ethylenediaminetetraacetic acid, EDTA (Merck, Darmstadt, Germany) 
Ethanol (Merck, Darmstadt, Germany) 
Fetal calf serum, FCS (PromoCell, Heidelberg, Germany) 
Fixation medium, Solution A (ADG, Kaumberg, Austria) 
Liberase Blendzyme 3 (Roche Applied Science, Basel, Switzerland)  
Lymphoprep (Axis Shield, Rodelokka, Norway) 
Mounting medium for cryostat sections (Vector Laboratories Inc., Burlingame, CA, 
USA) 
Mounting medium for sheets (Difco Bacto, BD, Franklin Lakes, NJ, USA) 
Optimum cutting temperature formulation (O.C.T., Tissue-Tek, Sakura Finetek, 
Zoeterwoude, The Netherlands) 
Phosphate-buffered saline, PBS (Invitrogen, Lofer, Austria) 
Saponin (Sigma-Aldrich, St. Louis, MO, USA) 
Trypan blue, 0.4% (Sigma-Aldrich, St. Louis, MO, USA) 
 46  
  
Trypsin cryst. lyophalizied (Merck, Darmstadt, Germany) 
 
6.4  Buffers and media 
6.4.1  10x DNAse 
RPMI 1640 (Gibco) supplemented with:  10% FCS (PromoCell) 
 1x penicillin/streptomycin (Gibco) 
  100 mg DNAse (Invitrogen) 
 
6.4.2  Wash medium 
RPMI 1640 (Gibco) supplemented with:  10% FCS (PromoCell) 
   1x penicillin/streptomycin (Gibco) 
 
6.4.3  0.8% Trypsin 
1x PBS (Invitrogen) supplemented with:  4 g Trypsin cryst. lyophalizied (Merck) 
  
6.4.4  FACS Buffer 
1x PBS (Invitrogen) supplemented with: 1% FCS (PromoCell)   
  0.5 mM EDTA (Merck) 
 
6.4.5  MACS Buffer 
1x PBS (Invitrogen) supplemented with:  0.5% BSA (Sigma-Aldrich) 
   2 mM EDTA (Merck) 
 
6.5  Skin preparation and cell isolation 
6.5.1  Preperation of epidermal single cell suspensions 
Skin samples were obtained from infants (28 days to 24 months), young children (3 
to 5 years), old children (6 to 11 years), adolescents (12 to 17 years) and adults (18 
to 49 years). Human foreskin (routine circumcisions), normal human breast skin 
(mammary reduction), normal gluteal and belly skin were obtained as discarded 
material after the ethical committee approval of the Medical University of Vienna. 
Skin samples were stored at 4°C in PBS until use and pro cessed no longer than 6 
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hours after surgery. For the preparation of single epidermal cell suspensions, 
subcutaneous tissue was removed and remaining skin was disinfected by incubation 
in Betaisodona for approximately 10 min, followed by a short plunge in 70% ethanol 
and another incubation in PBS for 1-2 min. Then skin was cut into small stripes and 
placed epidermal side up on 25% dispase (over night, 4°C). On the next day, the 
epidermis was separated from the dermis with forceps and digested in 5 ml PBS, 2 
ml 0.8% trypsin and 1 ml 10x DNAse (12 min, 37°C). Th e digested epidermis was 
sifted through a 70 µm cell strainer and the enzymatic reaction of trypsin was 
stopped by the addition of 30 ml wash medium. The obtained cells were washed and  
resuspended in 500 µl MACS buffer. An aliquot was stained with trypan blue and the 
numbers of viable cells were determined with a Neubauer counting chamber. 
 
6.5.2  Preperation of dermal single cell suspensions 
The preparation process is identical with that described for the preparation of an 
epidermal single cells suspension until the separation step of the epidermis from the 
dermis. Dermis was digested in 15 ml PBS and Liberase Blendzyme 3 (10.7 Units; 2 
hours, 37°C). Subsequently, the digested dermis was sift ed through a 70 µm cell 
strainer and washed with 40 ml wash medium and 1 ml 10xDNAse solution. Isolated 
cells were resuspended in 500 µl MACS buffer, and viability of the cells was 
determined as described in 6.5.1. 
 
6.5.3  Preperation of skin single cell suspensions 
The preparation process was identical with that described above. Upon incubation in 
PBS (1-2 min), skin was cut as small as possible and digested in 15 ml PBS and 
Liberase Blendzyme 3 (10.7 Units; 2 hours, 37°C). Subse quently, the digested skin 
was sifted through a 70 µm cell strainer and washed with 40 ml wash medium and 1 
ml 10xDNAse solution. Isolated cells were resuspended in 500 µl MACS buffer, and 
cell viability was dertermined as described in 6.5.1. 
 
6.5.4  Preparation of human epidermal sheets 
The preparation process was identical with that for the preparation of an epidermal 
single cell suspension until the removal of subcutaneous tissue from the samples. 
Skin was cut into small squares (approximately 1 cm2) and placed on a 3.8% 
ammonium thiocyanate solution with the epidermal side up (30 min, 37°C). Then the 
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epidermis was separated from the dermis and washed in PBS (10 min, room 
temperature). Thereafter, the epidermis was fixed in acetone (10 min, room 
temperature), washed in PBS (10 min, room temperature), and incubated in 50 µl of 
a purified anti-RANK antibody (Ab) solution in a 96-well flat bottom cell culture plate 
(over night, 4°C). After two washing steps in PBS (5 m in, room temperature), 50 µl of 
an AlexaFluor-546 F(ab’)2 goat anti-mouse IgG dilution were added per well to the 
sheets (2 hours, room temperature, dark). After two washing steps in PBD (5 min, 
room temperature), the sheets were incubated in 50 µl of an anti-CD1a-FITC Ab 
solution (over nights, 4°C, dark). Finally, the sheets  were washed again (twice, 5 min, 
room temperature, dark), placed on microscope slides, mounted with mounting media 
and covered with microscope cover glasses. Control samples were stained with 
appropriate isotype Ab. Images were recorded using a CLSM 510 Confocal laser 
scanning microscope. 
 
6.5.5  Isolation of PBMCs 
Buffy coats from peripheral blood of healthy adult volunteers were purchased from 
the local transfusion service (Rotes Kreuz, Vienna, Austria). PBMCs were isolated as 
interface cells after density gradient centrifugation and erythrocytes were removed 
with ammonium chloride (0.8% NH4Cl/0.1 mM EDTA). Isolated cells were 
resuspended in 500 µl MACS buffer, an aliquot of the cells was stained with trypan 
blue and their viability and numbers were determined with a Neubauer counting 
chamber.  
 
6.6  Flow Cytometry 
Skin or epidermal single cell suspensions were incubated in microtubes                
(100 µl/sample) with APC-, FITC-, PE-conjugated or purified Ab (30 min, 4°C, dark). 
Then, cells were washed with FACS buffer and when a purified Ab was used, a PE-
conjugate was added to this staining. To analyze intracellular antigens, cells were 
permebailized and fixed with Solution A (1 ml/ml; room temperature, 15 min). 
Afterwards, the cells were washed with 0.1% saponin/PBS and stained with an 
appropriate conjugated Ab. Dead cells were excluded by 7-AAD (1 µg/ml) and cells 
were analyzed with a FACS Calibur cytometer. Data were analyzed with FlowJo 
software. Control samples were stained with appropriate isotype-matched Ab. To 
determine the percentage of different subsets of cells (e.g. RANK+CD1a+ cells), gates 
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were set (Figure 3A) based on isotype controls. The percentage of the upper right 
gate was divided through the summed up percentages of the lower and upper right 
gates, and multiplied with 100.  
 
6.7  Immunofluorescence 
Skin specimens from selected age groups were embedded in O.C.T., snap-frozen in 
liquid nitrogen and stored at –80°C until further pr ocessing. Five µm sections were 
cut, transferred onto capillary gap microscope slides, fixed in ice-cold acetone for 10 
min and air-dried. Sections were incubated with 10% normal mouse serum and 1% 
purified mouse-IgG1 Ab (20 min, room temperature). To stain memory T cells, 
sections were incubated (over night, 4°C) with a purifi ed anti-CD45RO mAb dilution. 
Skin sections were washed in PBS (3x10 min) and incubated with an AlexaFluor-546 
F(ab’)2 goat anti-mouse IgG dilution (2 hours, room temperature). Afterwards, the 
samples were washed again in PBS (3x10 min), blocked with 10% normal mouse 
serum and 1% purified mouse IgG1 Ab (20 min, room temperature), incubated with 
an anti-CD3-FITC-conjugated mAb (over night, 4°C), a nd mounted with fluorescence 
mounting medium. 
To stain naive T cells, sections were simultaneously incubated with anti-CD45RA-PE 
and anti-CD3-FITC mAbs (over night, 4°C), washed in P BS (3x10 min) and mounted 
with fluorescence mounting medium. Control samples were stained with appropriate 
isotype-matched Ab and images were taken with a Nikon eclipse 80i optical 
microscope. For the enumeration of naive and memory T cells, at least 10 images 
per donor were taken. Then epidermis and dermis were measured and the numbers 
of single and double positive cells were determined and placed in relation. 
Measurement and counting was made with Lucia general software.  
 
6.8  Statistical analysis 
The gained values were compared in a statistic diagram designed with the GraphPad 
Prism 5 software. P-values were calculated with the Mann-Whitney–U test. 
Significance results at p-values smaller than 5%. 
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Table 1. Antibodies & second-step reagents 
AB specifity Clone Ig Class Working dilution Source* Conjugate 
CD1a HI149 Mouse IgG1, κ 1:100 Biolegend AlexaFluor-488 
CD1a HI149 Mouse IgG1, κ 1:100 BD Pharmingen APC, PE, FITC 
CD3 SK7 Mouse IgG1, κ 1:100 BD Pharmingen APC 
CD3 UCHT1 Mouse IgG1, κ 1:50 ADG FITC 
CD45RA T6D11 Mouse IgG2b, κ 1:50 Miltenyi PE 
CD45RO UCHL1 Mouse IgG2a, κ 1:50 BD Pharmingen PE 
CD45RO UCHL1 Mouse IgG2a, κ 1:50 AbD Purified 
CD117 YB5.B8 Mouse IgG1, κ 1:100 BD Pharmingen PE 
CLA HECA-452 Rat IgM, κ 1:50 BD Pharmingen FITC 
Pancytokeratin C-11 Mouse IgG1, κ 1:500 Abcam FITC 
RANK 80704 Mouse IgG1, κ 1:100 R&D Systems purified 
Second-step reagents 
Goat anti-mouse F(ab')2 IgG (H+L) 1:250 Invitrogen AlexaFluor-546 
Goat anti-mouse Goat F(ab')2 IgG + IgM (H+L) 1:250 Dako PE 
 
*Abcam, Cambridge, United Kingdom; AbD Serotec, Kidlington, United Kingdom; ADG, Kaumberg, Austria; BD 
Pharmingen, San Diego, CA, USA; Biolegend, San Diego, CA, USA; Dako, Glostrup, Denmark; Miltenyi Biotech, 
Bergisch Gladbach, Germany; R&D Systems, Minneapolis, MN, USA. 
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